Kiniksa Pharmaceuticals International, plc (KNSA) Net Income by Year
Kiniksa Pharmaceuticals International, plc reported $59.0M in net income in fiscal year 2025. This represents an increase of 236.6% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $73.1M in net income. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Kiniksa Pharmaceuticals International, plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
KNSA Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
KNSA Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Kiniksa Pharmaceuticals International, plc financials
Frequently Asked Questions
What was Kiniksa Pharmaceuticals International, plc's net income in fiscal year 2025?
Kiniksa Pharmaceuticals International, plc reported $59.0M in net income in fiscal year 2025.
How fast is Kiniksa Pharmaceuticals International, plc's net income growing?
Kiniksa Pharmaceuticals International, plc (KNSA) net income rose by 236.6% year over year, from -$43.2M to $59.0M in fiscal year 2025.
What is Kiniksa Pharmaceuticals International, plc's net income over the last twelve months?
Kiniksa Pharmaceuticals International, plc (KNSA) reported $73.1M in net income over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
How has Kiniksa Pharmaceuticals International, plc's net income changed over the years?
Across the 9 fiscal years this page covers, Kiniksa Pharmaceuticals International, plc (KNSA) net income went from -$64.9M in fiscal year 2017 to $59.0M in fiscal year 2025.
What was Kiniksa Pharmaceuticals International, plc's net income in the most recent quarter?
Kiniksa Pharmaceuticals International, plc (KNSA) reported $22.6M in net income in Q1 2026. This represents an increase of 164.6% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Kiniksa Pharmaceuticals International, plc (KNSA) reported on that line in every period on record.